GCM
CDLX icon

Graham Capital Management’s Cardlytics CDLX Stock Holding History

Graham Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,621
Closed -$361K – 1084
2022
Q2 		$361K Buy
+1,621
New +$543K 0.01% 766

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Graham Capital Management's CDLX Position: Q3 2022 in Review

Graham Capital Management sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 1,621 shares — an estimated $361K sold.

Graham Capital Management first reported a position in CDLX in Q2 2022 and held it in 1 quarter. The position peaked at $361K in Q2 2022. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Graham Capital Management reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Graham Capital Management sold 1,621 Cardlytics shares in Q3 2022, an estimated $361K.
  • Graham Capital Management first reported a position in Cardlytics in Q2 2022 and held it in 1 quarter.
  • Graham Capital Management's Cardlytics position peaked at $361K in Q2 2022.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Graham Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.